Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Strongbridge Biopharma Plc (SBBP)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Lyon Street Capital

Brian C. Freckmann

2,858,928 $13,866 -38% 8.63%
2.
Opaleye Management

James A. Silverman

1,730,000 $8,390 -6% 2.13%
3.
Broadfin Capital

Kevin Kotler

2,563,096 $12,431 +10% 1.82%
4.
Prosight Capital

Lawrence Hawkins

423,846 $2,056 1.14%
5. 2,650,000 $12,853 +23% 0.77%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.93 360,995 Large Shareholder 6,294,829 2018-08-08 Filing
$4.66 70,000 Large Shareholder 5,933,834 2018-07-30 Filing
$4.85 92,400 Large Shareholder 5,863,384 2018-07-27 Filing
$4.63 116,900 Large Shareholder 5,771,434 2018-07-27 Filing
$4.94 39,800 Large Shareholder 5,654,534 2018-07-26 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 6,294,789 $30,530 28.22%
2. 4,141,308 $20,085 0.86%
3. 1,179,010 $5,718 0.65%
4. 918,132 $4,453 0.44%
5. 434,161 $2,106 0.24%